{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:37:43Z","timestamp":1785818263208,"version":"3.56.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.tem.2010.03.004","type":"journal-article","created":{"date-parts":[[2010,4,30]],"date-time":"2010-04-30T05:04:28Z","timestamp":1272603868000},"page":"464-472","source":"Crossref","is-referenced-by-count":70,"title":["Neonatal diabetes mellitus: A model for personalized medicine"],"prefix":"10.1016","volume":"21","author":[{"given":"Siri Atma W.","family":"Greeley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rochelle N.","family":"Naylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme I.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis H.","family":"Philipson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2010.03.004_bib1","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1464-5491.2008.02459.x","article-title":"Prevalence of HNF1A (MODY3) mutations in a Norwegian population (the HUNT2 Study)","volume":"25","author":"Eide","year":"2008","journal-title":"Diabet. Med."},{"key":"10.1016\/j.tem.2010.03.004_bib2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ncpendmet0778","article-title":"Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes","volume":"4","author":"Murphy","year":"2008","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"issue":"Suppl. 12","key":"10.1016\/j.tem.2010.03.004_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1399-5448.2009.00571.x","article-title":"The diagnosis and management of monogenic diabetes in children and adolescents","volume":"10","author":"Hattersley","year":"2009","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.tem.2010.03.004_bib4","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/archpedi.1947.02030010601004","article-title":"Diabetes mellitus in infants under one year of age; report of a case and review of the literature","volume":"74","author":"Schwartzman","year":"1947","journal-title":"Am. J. Dis. Child"},{"key":"10.1016\/j.tem.2010.03.004_bib5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/adc.30.151.291","article-title":"Transient diabetes in infancy","volume":"30","author":"Keidan","year":"1955","journal-title":"Arch. Dis. Child"},{"key":"10.1016\/j.tem.2010.03.004_bib6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archpedi.1979.02130010071012","article-title":"Transient neonatal diabetes mellitus. Treatment with chlorpropamide","volume":"133","author":"Kuna","year":"1979","journal-title":"Am. J. Dis. Child"},{"key":"10.1016\/j.tem.2010.03.004_bib7","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1651-2227.1989.tb11114.x","article-title":"Transient neonatal diabetes mellitus in a pair of twins","volume":"78","author":"Nielsen","year":"1989","journal-title":"Acta Paediatr. Scand."},{"key":"10.1016\/j.tem.2010.03.004_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1034\/j.1399-0039.2000.560303.x","article-title":"HLA-DRB1 and DQB1 genotypes in patients with insulin-dependent neonatal diabetes mellitus. A study of 13 cases","volume":"56","author":"Marquis","year":"2000","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.tem.2010.03.004_bib9","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.2337\/db06-0094","article-title":"HLA genotyping supports a nonautoimmune etiology in patients diagnosed with diabetes under the age of 6 months","volume":"55","author":"Edghill","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2010.03.004_bib10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ng0295-110","article-title":"An imprinted gene(s) for diabetes?","volume":"9","author":"Temple","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tem.2010.03.004_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00439-001-0671-5","article-title":"Relaxation of imprinted expression of ZAC and HYMAI in a patient with transient neonatal diabetes mellitus","volume":"110","author":"Mackay","year":"2002","journal-title":"Hum. Genet."},{"key":"10.1016\/j.tem.2010.03.004_bib12","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0197-106","article-title":"Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence","volume":"15","author":"Stoffers","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tem.2010.03.004_bib13","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1210\/jc.2003-030046","article-title":"Agenesis of human pancreas due to decreased half-life of insulin promoter factor 1","volume":"88","author":"Schwitzgebel","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2010.03.004_bib14","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1399-5448.2009.00526.x","article-title":"Neonatal diabetes mellitus with pancreatic agenesis in an infant with homozygous IPF-1 Pro63fsX60 mutation","volume":"10","author":"Thomas","year":"2009","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.tem.2010.03.004_bib15","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2337\/db09-1284","article-title":"A novel hypomorphic PDX1 mutation responsible for permanent neonatal diabetes with subclinical exocrine deficiency","volume":"59","author":"Nicolino","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2010.03.004_bib16","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1056\/NEJM200105243442104","article-title":"Neonatal diabetes mellitus due to complete glucokinase deficiency","volume":"344","author":"Njolstad","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2010.03.004_bib17","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/78085","article-title":"EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome","volume":"25","author":"Delepine","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tem.2010.03.004_bib18","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1210\/jc.2009-1137","article-title":"Wolcott-Rallison syndrome is the most common genetic cause of permanent neonatal diabetes in consanguineous families","volume":"94","author":"Rubio-Cabezas","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2010.03.004_bib19","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/ng1475","article-title":"Mutations in PTF1A cause pancreatic and cerebellar agenesis","volume":"36","author":"Sellick","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tem.2010.03.004_bib20","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/j.1464-5491.2006.01999.x","article-title":"Hepatocyte nuclear factor-1 beta mutations cause neonatal diabetes and intrauterine growth retardation: support for a critical role of HNF-1beta in human pancreatic development","volume":"23","author":"Edghill","year":"2006","journal-title":"Diabet. Med."},{"key":"10.1016\/j.tem.2010.03.004_bib21","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1210\/jc.2003-031828","article-title":"Neonatal diabetes mellitus and neonatal polycystic, dysplastic kidneys: phenotypically discordant recurrence of a mutation in the hepatocyte nuclear factor-1beta gene due to germline mosaicism","volume":"89","author":"Yorifuji","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2010.03.004_bib22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2337\/dc08-1188","article-title":"Clinical heterogeneity in patients with FOXP3 mutations presenting with permanent neonatal diabetes","volume":"32","author":"Rubio-Cabezas","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2010.03.004_bib23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/83707","article-title":"X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy","volume":"27","author":"Wildin","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tem.2010.03.004_bib24","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ng1802","article-title":"Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism","volume":"38","author":"Senee","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tem.2010.03.004_bib25","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa032922","article-title":"Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes","volume":"350","author":"Gloyn","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2010.03.004_bib26","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1056\/NEJMoa055068","article-title":"Activating mutations in the ABCC8 gene in neonatal diabetes mellitus","volume":"355","author":"Babenko","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2010.03.004_bib27","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/hmg\/ddl101","article-title":"A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes","volume":"15","author":"Proks","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tem.2010.03.004_bib28","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1086\/519174","article-title":"Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects","volume":"81","author":"Ellard","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tem.2010.03.004_bib29","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.2337\/db07-0043","article-title":"Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood","volume":"56","author":"Flanagan","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2010.03.004_bib30","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.2337\/db06-1540","article-title":"New ABCC8 mutations in relapsing neonatal diabetes and clinical features","volume":"56","author":"Vaxillaire","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2010.03.004_bib31","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/embor.2008.71","article-title":"A mutation (R826W) in nucleotide-binding domain 1 of ABCC8 reduces ATPase activity and causes transient neonatal diabetes","volume":"9","author":"de Wet","year":"2008","journal-title":"EMBO Rep."},{"key":"10.1016\/j.tem.2010.03.004_bib32","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.2337\/diabetes.53.10.2713","article-title":"Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy","volume":"53","author":"Sagen","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2010.03.004_bib33","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.2337\/diabetes.53.10.2719","article-title":"Kir6.2 mutations are a common cause of permanent neonatal diabetes in a large cohort of French patients","volume":"53","author":"Vaxillaire","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2010.03.004_bib34","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.1210\/jc.2004-1241","article-title":"Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2","volume":"89","author":"Zung","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2010.03.004_bib35","doi-asserted-by":"crossref","first-page":"758","DOI":"10.2337\/diacare.28.3.758","article-title":"High-dose glibenclamide can replace insulin therapy despite transitory diarrhea in early-onset diabetes caused by a novel R201L Kir6.2 mutation","volume":"28","author":"Codner","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2010.03.004_bib36","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/hmg\/ddi086","article-title":"Relapsing diabetes can result from moderately activating mutations in KCNJ11","volume":"14","author":"Gloyn","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tem.2010.03.004_bib37","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00125-005-1731-5","article-title":"The identification of a R201H mutation in KCNJ11, which encodes Kir6.2, and successful transfer to sustained-release sulphonylurea therapy in a subject with neonatal diabetes: evidence for heterogeneity of beta cell function among carriers of the R201H mutation","volume":"48","author":"Klupa","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2010.03.004_bib38","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/humu.20124","article-title":"KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes","volume":"25","author":"Massa","year":"2005","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.tem.2010.03.004_bib39","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1007\/s00125-006-0246-z","article-title":"Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype","volume":"49","author":"Flanagan","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2010.03.004_bib40","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/sj.ejhg.5201629","article-title":"KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features","volume":"14","author":"Gloyn","year":"2006","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.tem.2010.03.004_bib41","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1210\/jc.2005-0096","article-title":"The C42R mutation in the Kir6.2 (KCNJ11) gene as a cause of transient neonatal diabetes, childhood diabetes, or later-onset, apparently type 2 diabetes mellitus","volume":"90","author":"Yorifuji","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2010.03.004_bib42","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1007\/s00125-006-0329-x","article-title":"Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene","volume":"49","author":"Tonini","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2010.03.004_bib43","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.2337\/dc06-0487","article-title":"Treatment of hyperglycemia in a 7-year-old child diagnosed with neonatal diabetes","volume":"29","author":"Hathout","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2010.03.004_bib44","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1056\/NEJMoa061759","article-title":"Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations","volume":"355","author":"Pearson","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2010.03.004_bib45","doi-asserted-by":"crossref","first-page":"15040","DOI":"10.1073\/pnas.0707291104","article-title":"Insulin gene mutations as a cause of permanent neonatal diabetes","volume":"104","author":"Stoy","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2010.03.004_bib46","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nature08748","article-title":"Rfx6 directs islet formation and insulin production in mice and humans","volume":"463","author":"Smith","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.tem.2010.03.004_bib47","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1399-5448.2007.00231.x","article-title":"Transition from insulin to glyburide in a 4-month-old girl with neonatal diabetes mellitus caused by a mutation in KCNJ11","volume":"8","author":"Chan","year":"2007","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.tem.2010.03.004_bib48","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.2337\/dc07-1196","article-title":"Sulfonylrea treatment in permanent neonatal diabetes due to G53D mutation in the KCNJ11 gene: improvement in glycemic control and neurological function","volume":"30","author":"Gurgel","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2010.03.004_bib49","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2337\/dc06-1628","article-title":"Transfer to sulphonylurea therapy in adult subjects with permanent neonatal diabetes due to KCNJ11-activating [corrected] mutations: evidence for improvement in insulin sensitivity","volume":"30","author":"Malecki","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2010.03.004_bib50","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1399-5448.2007.00316.x","article-title":"Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJ11 activating mutation from subcutaneous insulin to oral glyburide","volume":"9","author":"Bremer","year":"2008","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.tem.2010.03.004_bib51","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1210\/jc.2007-1826","article-title":"The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy","volume":"93","author":"Koster","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2010.03.004_bib52","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1399-5448.2009.00548.x","article-title":"Medical and developmental impact of transition from subcutaneous insulin to oral glyburide in a 15-yr old boy with neonatal diabetes mellitus and intermediate DEND syndrome: extending the age of KCNJ11 mutation testing in neonatal DM","volume":"11","author":"Mohamadi","year":"2010","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.tem.2010.03.004_bib53","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2337\/diaclin.27.1.25","article-title":"Case study: transitioning from insulin to glyburide in permanent neonatal diabetes: medical and psychosocial challenges in an 18-year-old male","volume":"27","author":"Monaghan","year":"2009","journal-title":"Clin. Diabetes"},{"key":"10.1016\/j.tem.2010.03.004_bib54","doi-asserted-by":"crossref","unstructured":"Wambach, J.A. et al. (2009) Successful sulfonylurea treatment of an insulin-naive neonate with diabetes mellitus due to a KCNJ11 mutation. Pediatr. Diabetes Epub: July 29, 2009, DOI: 10.1111\/j.1399-5448.2009.00557.x","DOI":"10.1111\/j.1399-5448.2009.00557.x"},{"key":"10.1016\/j.tem.2010.03.004_bib55","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jpeds.2007.03.004","article-title":"Sulfonylurea-responsive diabetes in childhood","volume":"150","author":"Landau","year":"2007","journal-title":"J. Pediatr."},{"key":"10.1016\/j.tem.2010.03.004_bib56","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1210\/jc.2006-2490","article-title":"Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers","volume":"92","author":"Stanik","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2010.03.004_bib57","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1464-5491.2007.02140.x","article-title":"The majority of cases of neonatal diabetes in Spain can be explained by known genetic abnormalities","volume":"24","author":"Rica","year":"2007","journal-title":"Diabet. Med."},{"key":"10.1016\/j.tem.2010.03.004_bib58","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1210\/jc.2007-0486","article-title":"Molecular basis of neonatal diabetes in Japanese patients","volume":"92","author":"Suzuki","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2010.03.004_bib59","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1399-5448.2008.00433.x","article-title":"Diagnosis and treatment of neonatal diabetes: a United States experience","volume":"9","author":"Stoy","year":"2008","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.tem.2010.03.004_bib60","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1515\/JPEM.2008.21.9.895","article-title":"Familial permanent neonatal diabetes with KCNJ11 mutation and the response to glyburide therapy \u2013 a three-year follow-up","volume":"21","author":"Begum-Hasan","year":"2008","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2010.03.004_bib61","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1464-5491.2009.02711.x","article-title":"Diabetic retinopathy in permanent neonatal diabetes due to Kir6.2 gene mutations: the results of a minimum 2-year follow-up after the transfer from insulin to sulphonylurea","volume":"26","author":"Klupa","year":"2009","journal-title":"Diabet. Med."},{"key":"10.1016\/j.tem.2010.03.004_bib62","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2337\/dc07-1785","article-title":"Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations","volume":"31","author":"Rafiq","year":"2008","journal-title":"Diabetes Care"},{"issue":"Suppl. 12","key":"10.1016\/j.tem.2010.03.004_bib63","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1399-5448.2009.00583.x","article-title":"Assessment and management of hypoglycemia in children and adolescents with diabetes","volume":"10","author":"Clarke","year":"2009","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.tem.2010.03.004_bib64","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.2337\/dc09-0280","article-title":"Tooth discoloration in patients with neonatal diabetes after transfer onto glibenclamide: a previously unreported side effect","volume":"32","author":"Kumaraguru","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2010.03.004_bib65","first-page":"80","article-title":"Expression of an activating mutation in the gene encoding the KATP channel subunit Kir6.2 in mouse pancreatic beta cells recapitulates neonatal diabetes","volume":"119","author":"Girard","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2010.03.004_bib66","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.cmet.2008.12.005","article-title":"Secondary consequences of beta cell inexcitability: identification and prevention in a murine model of K(ATP)-induced neonatal diabetes mellitus","volume":"9","author":"Remedi","year":"2009","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2010.03.004_bib67","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2337\/db06-1275","article-title":"An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of developmental delay, epilepsy, and neonatal diabetes","volume":"56","author":"Masia","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2010.03.004_bib68","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1464-5491.2007.02228.x","article-title":"Sulphonylurea treatment does not improve psychomotor development in children with KCNJ11 mutations causing permanent neonatal diabetes mellitus accompanied by developmental delay and epilepsy (DEND syndrome)","volume":"24","author":"Sumnik","year":"2007","journal-title":"Diabet. Med."},{"key":"10.1016\/j.tem.2010.03.004_bib69","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1590\/S0004-27302008000800024","article-title":"Glibenclamide unresponsiveness in a Brazilian child with permanent neonatal diabetes mellitus and DEND syndrome due to a C166Y mutation in KCNJ11 (Kir6.2) gene","volume":"52","author":"Della Manna","year":"2008","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"key":"10.1016\/j.tem.2010.03.004_bib70","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1007\/s00125-006-0407-0","article-title":"Improved motor development and good long-term glycaemic control with sulfonylurea treatment in a patient with the syndrome of intermediate developmental delay, early-onset generalised epilepsy and neonatal diabetes associated with the V59M mutation in the KCNJ11 gene","volume":"49","author":"Slingerland","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2010.03.004_bib71","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3346\/jkms.2007.22.4.616","article-title":"Sulfonylurea therapy in two Korean patients with insulin-treated neonatal diabetes due to heterozygous mutations of the KCNJ11 gene encoding Kir6.2","volume":"22","author":"Kim","year":"2007","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.tem.2010.03.004_bib72","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1464-5491.2007.02373.x","article-title":"Sulphonylurea therapy improves cognition in a patient with the V59M KCNJ11 mutation","volume":"25","author":"Slingerland","year":"2008","journal-title":"Diabet. Med."},{"key":"10.1016\/j.tem.2010.03.004_bib73","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1515\/JPEM.2009.22.7.661","article-title":"Improved diabetic control during oral sulfonylurea treatment in two children with permanent neonatal diabetes mellitus","volume":"22","author":"Ting","year":"2009","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2010.03.004_bib74","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0079-6107(02)00053-6","article-title":"Physiological and pathophysiological roles of ATP-sensitive K+ channels","volume":"81","author":"Seino","year":"2003","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.tem.2010.03.004_bib75","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yjmcc.2004.11.024","article-title":"Function and distribution of the SUR isoforms and splice variants","volume":"39","author":"Shi","year":"2005","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.tem.2010.03.004_bib76","doi-asserted-by":"crossref","first-page":"C25","DOI":"10.1152\/ajpcell.1998.274.1.C25","article-title":"ATP-sensitive K+ channels in pancreatic, cardiac, and vascular smooth muscle cells","volume":"274","author":"Yokoshiki","year":"1998","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.tem.2010.03.004_bib77","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0014-5793(96)01438-X","article-title":"Overlapping distribution of K(ATP) channel-forming Kir6.2 subunit and the sulfonylurea receptor SUR1 in rodent brain","volume":"401","author":"Karschin","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tem.2010.03.004_bib78","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00424-006-0116-z","article-title":"ABCC8 and ABCC9: ABC transporters that regulate K(+) channels","volume":"453","author":"Bryan","year":"2007","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.tem.2010.03.004_bib79","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.2337\/diabetes.54.9.2503","article-title":"Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy","volume":"54","author":"Hattersley","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2010.03.004_bib80","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/ncpneuro0640","article-title":"Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11","volume":"3","author":"Mlynarski","year":"2007","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.tem.2010.03.004_bib81","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1212\/01.wnl.0000268488.51776.53","article-title":"A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain","volume":"69","author":"Shimomura","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.tem.2010.03.004_bib82","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00439-004-1236-1","article-title":"Bisulphite sequencing of the transient neonatal diabetes mellitus DMR facilitates a novel diagnostic test but reveals no methylation anomalies in patients of unknown aetiology","volume":"116","author":"Mackay","year":"2005","journal-title":"Hum. Genet."},{"key":"10.1016\/j.tem.2010.03.004_bib83","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.2337\/diabetes.49.8.1359","article-title":"Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes","volume":"49","author":"Temple","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2010.03.004_bib84","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1067\/mpd.2002.127089","article-title":"Neonatal diabetes mellitus: chromosomal analysis in transient and permanent cases","volume":"141","author":"Metz","year":"2002","journal-title":"J. Pediatr."},{"key":"10.1016\/j.tem.2010.03.004_bib85","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1210\/en.141.6.1926","article-title":"Perspective: postnatal pancreatic beta cell growth","volume":"141","author":"Bonner-Weir","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2010.03.004_bib86","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.2337\/db07-1369","article-title":"Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans","volume":"57","author":"Meier","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2010.03.004_bib87","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1172\/JCI200419876","article-title":"Impaired glucose homeostasis in transgenic mice expressing the human transient neonatal diabetes mellitus locus, TNDM","volume":"114","author":"Ma","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2010.03.004_bib88","doi-asserted-by":"crossref","first-page":"F341","DOI":"10.1136\/adc.2003.030502","article-title":"An assessment of pancreatic endocrine function and insulin sensitivity in patients with transient neonatal diabetes in remission","volume":"89","author":"Shield","year":"2004","journal-title":"Arch. Dis. Child Fetal Neonatal Ed."},{"key":"10.1016\/j.tem.2010.03.004_bib89","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.2337\/diacare.27.10.2405","article-title":"Beta-cell dysfunction in classic transient neonatal diabetes is characterized by impaired insulin response to glucose but normal response to glucagon","volume":"27","author":"Valerio","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2010.03.004_bib90","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.2337\/dc08-1813","article-title":"Long-standing sulfonylurea therapy after pubertal relapse of neonatal diabetes in a case of uniparental paternal isodisomy of chromosome 6","volume":"32","author":"Schimmel","year":"2009","journal-title":"Diabetes Care"},{"issue":"Suppl. 2","key":"10.1016\/j.tem.2010.03.004_bib91","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1463-1326.2007.00772.x","article-title":"Mutations in the ABCC8 gene encoding the SUR1 subunit of the KATP channel cause transient neonatal diabetes, permanent neonatal diabetes or permanent diabetes diagnosed outside the neonatal period","volume":"9","author":"Patch","year":"2007","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.tem.2010.03.004_bib92","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1464-5491.2008.02443.x","article-title":"Variable phenotypic spectrum of diabetes mellitus in a family carrying a novel KCNJ11 gene mutation","volume":"25","author":"D\u2019Amato","year":"2008","journal-title":"Diabet. Med."},{"key":"10.1016\/j.tem.2010.03.004_bib93","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2265.2008.03478.x","article-title":"Mutations in the ABCC8 (SUR1 subunit of the K(ATP) channel) gene are associated with a variable clinical phenotype","volume":"71","author":"Klupa","year":"2009","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.tem.2010.03.004_bib94","first-page":"2148","article-title":"Seven mutations in the human insulin gene linked to permanent neonatal\/infancy-onset diabetes mellitus","volume":"118","author":"Colombo","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2010.03.004_bib95","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.2337\/db07-1405","article-title":"Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood","volume":"57","author":"Edghill","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2010.03.004_bib96","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2337\/db07-1467","article-title":"Mutations in the insulin gene can cause MODY and autoantibody-negative type 1 diabetes","volume":"57","author":"Molven","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2010.03.004_bib97","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.2337\/db07-1358","article-title":"Heterozygous missense mutations in the insulin gene are linked to permanent diabetes appearing in the neonatal period or in early infancy: a report from the French ND (Neonatal Diabetes) Study Group","volume":"57","author":"Polak","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2010.03.004_bib98","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2337\/dc08-0783","article-title":"Insulin gene mutations as cause of diabetes in children negative for five type 1 diabetes autoantibodies","volume":"32","author":"Bonfanti","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2010.03.004_bib99","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2337\/db09-1091","article-title":"Insulin gene mutations resulting in a MODY phenotype: marked differences in clinical presentation, metabolic status and pathogenic effect through ER retention","volume":"59","author":"Meur","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2010.03.004_bib100","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1464-5491.2009.02812.x","article-title":"Testing for monogenic diabetes among children and adolescents with antibody-negative clinically defined Type 1 diabetes","volume":"26","author":"Rubio-Cabezas","year":"2009","journal-title":"Diabet. Med."},{"key":"10.1016\/j.tem.2010.03.004_bib101","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1073\/pnas.0910533107","article-title":"Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis","volume":"107","author":"Garin","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2010.03.004_bib102","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.bbrc.2009.12.090","article-title":"Mutant proinsulin proteins associated with neonatal diabetes are retained in the endoplasmic reticulum and not efficiently secreted","volume":"391","author":"Park","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tem.2010.03.004_bib103","doi-asserted-by":"crossref","first-page":"E403","DOI":"10.1152\/ajpendo.00592.2009","article-title":"In vitro processing and secretion of mutant insulin proteins that cause permanent neonatal diabetes","volume":"298","author":"Rajan","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2010.03.004_bib104","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1172\/JCI4431","article-title":"A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse","volume":"103","author":"Wang","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2010.03.004_bib105","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.2337\/db06-0658","article-title":"Dominant-negative effects of a novel mutated Ins2 allele causes early-onset diabetes and severe beta-cell loss in Munich Ins2C95S mutant mice","volume":"56","author":"Herbach","year":"2007","journal-title":"Diabetes"},{"issue":"Suppl. 4","key":"10.1016\/j.tem.2010.03.004_bib106","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1463-1326.2009.01106.x","article-title":"A brief perspective on insulin production","volume":"11","author":"Steiner","year":"2009","journal-title":"Diabetes Obes. Metab."}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276010000615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276010000615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T17:36:22Z","timestamp":1559064982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276010000615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":106,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S1043276010000615"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2010.03.004","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}